Braskie, Meredith
Assistant Professor of Neurology
We use neuroimaging, fluid biomarkers, environmental and genetic risk factors, and comorbidities to better understand Alzheimer’s disease (AD) risk - particularly the mechanisms underlying earliest brain characteristics that may signal or contribute to future cognitive decline. I am especially interested in the contributions of vascular, metabolic, and inflammatory risk to AD-relevant brain measures in older adults. I am also interested in disease heterogeneity and how it relates to health disparities and sex differences.
